About UsUnderstanding AMLInterviewsGlobal NetworkGet InvolvedStoriesResources

What’s new in immunotherapy for AML?

Naval Daver

December 15, 2020

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, Know AML spoke to Naval Daver, MD Anderson Cancer Center, Houston, US. We asked, What’s new in immunotherapy for AML? Daver gives an overview of the immunotherapies that have been approved or are in development for AML.